Nuveen’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,647
Closed -$116K 3415
2025
Q1
$116K Hold
21,647
﹤0.01% 3202
2024
Q4
$161K Buy
21,647
+8,037
+59% +$66.1K ﹤0.01% 3238
2024
Q3
$123K Hold
13,610
﹤0.01% 3295
2024
Q2
$145K Buy
+13,610
New +$145K ﹤0.01% 3274
2021
Q2
Sell
-14,536
Closed -$120K 3535
2021
Q1
$120K Hold
14,536
﹤0.01% 3273
2020
Q4
$94K Hold
14,536
﹤0.01% 3237
2020
Q3
$86K Hold
14,536
﹤0.01% 3224
2020
Q2
$102K Buy
+14,536
New +$106K ﹤0.01% 3159

Other funds holding ULBI

Nuveen's ULBI Position: Q2 2025 in Review

Nuveen sold out of Ultralife (ULBI) in Q2 2025, closing a stake of 21,647 shares — an estimated $116K sold.

Nuveen first reported a position in ULBI in Q2 2020 and held it in 8 quarters. The position peaked at $161K in Q4 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q2 2025.

  • Nuveen reported no remaining Ultralife position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 21,647 Ultralife shares in Q2 2025, an estimated $116K.
  • Nuveen first reported a position in Ultralife in Q2 2020 and held it in 8 quarters.
  • Nuveen's Ultralife position peaked at $161K in Q4 2024.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.